Hostname: page-component-6bf8c574d5-b4m5d Total loading time: 0 Render date: 2025-02-28T19:53:17.918Z Has data issue: false hasContentIssue false
  • English
  • Français

A Strategy to Improve Knowledge about Health Policies and Evidence Based Medicine for Federal Magistrates in Health Litigation

Published online by Cambridge University Press:  08 March 2023

Bruno Barcala Reis ,
Marcus Carvalho Borin ,
Marcelo Dolzany da Costa ,
Renato Luís Dresch ,
Osvaldo Oliveira Araújo Firmo ,
Melissa Cordeiro Guimarães ,
Carla Barbosa Morais Alves ,
Nelio Gomes Ribeiro Junior ,
Ludmila Peres Gargano  and
Túlio Tadeu Rocha Sarmento
...Show all authors
Bruno Barcala Reis
Affiliation:
PUBLIC DEFENDERS OFFICE OF THE STATE OF MINAS GERAIS, BRAZIL CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Marcus Carvalho Borin
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Marcelo Dolzany da Costa
Affiliation:
FEDERAL REGIONAL COURT OF THE 1ST REGION, STATE OF MINAS GERAIS, BRAZIL
Renato Luís Dresch
Affiliation:
TJMG – COURT OF APPEALS OF STATE OF MINAS GERAIS, BRAZIL
Osvaldo Oliveira Araújo Firmo
Affiliation:
TJMG – COURT OF APPEALS OF STATE OF MINAS GERAIS, BRAZIL
Melissa Cordeiro Guimarães
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Carla Barbosa Morais Alves
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Nelio Gomes Ribeiro Junior
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Ludmila Peres Gargano
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Túlio Tadeu Rocha Sarmento
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Pâmela Santos Azevedo
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Isabella de Figueiredo Zuppo
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Carolina Zampirolli Dias
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Vania Cristina Canuto dos Santos
Affiliation:
DGITIS – DEPARTMENT OF MANAGEMENT AND INCORPORATION OF TECHNOLOGIES AND INNOVATION IN HEALTH, SCTIE, MINISTRY OF HEALTH, BRAZIL
Juliana Alvares-Teodoro
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Francisco de Assis Acurcio
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Augusto Afonso Guerra Junior
Affiliation:
CCATES – SUS COLLABORATING CENTER FOR HEALTH TECHNOLOGY ASSESSMENT AT UFMG, BRAZIL
Get access Rights & Permissions [Opens in a new window]

Abstract

Several countries maintain universal health coverage, which implies responsibility to organize delivery formats of healthcare services and products for citizens. In Brazil, the health system has a principle of universal access for more than 30 years, but many deficiencies remain and the country observes a day practice for those seeking judicial decisions to determine provision of healthcare.

Keywords

Academic DetailingHealth LitigationHealth AuthorityUniversal Health CoverageHealth Law
Type
Independent Articles
Information
Journal of Law, Medicine & Ethics , Volume 50 , Issue 4: Health Justice: Engaging Critical Perspectives in Health Law and Policy , Winter 2022 , pp. 807 - 817
Copyright
© 2023 The Author(s)

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Stevens, F. C. J. and van der Zee, J., “Health System Organization Models (Including Targets and Goals for Health Systems),” International Encyclopedia of Public Health (London: Elsevier, 2008): 247–256, doi.org/10.1016/B978-012373960-5.00309-9.CrossRefGoogle Scholar
Chieffi, A. L., Barradas, R. D. C. B., and Golbaum, M., “Legal Access to Medications: A Threat to Brazil’s Public Health System?” BMC Health Services Research 17 (2017): 499, doi.org/10.1186/s12913-017-2430-x; J. de O. Costa, C. C. Almeida-Brasil, B. Godman, M. A. Fischer, J. Dartnell, A. Heaney, C. G. B. dos Santos, F. de A. Acurcio, J. Álvares, and A. A. Guerra, “Implementation of Clinical Guidelines in Brazil: Should Academic Detailing be Used?” Journal of Pharmaceutical Health Services Research 7 (2016): 105–115, doi.org/10.1111/jphs.12133.CrossRefGoogle ScholarPubMed
Massuda, A., Hone, T., Leles, F. A. G., de Castro, M. C., and Atun, R., “The Brazilian Health System at Crossroads: Progress, Crisis and Resilience,” BMJ Global Health 3 (2018) e000829, doi.org/10.1136/bmjgh-2018-000829.CrossRefGoogle ScholarPubMed
Machado, F. R. de S., “Contribuições ao Debate da Judicialização da Saúde no Brasil,” Revista de Direito Sanitário 9 (2008): 73, doi.org/10.11606/issn.2316-9044.v9i2p73-91; M. A. de Á. Machado, F. de A. Acurcio, C. M. R. Brandão, D. R. Faleiros, A. A. Guerra Jr, M. L. Cherchiglia, and E. I. G. Andrade, “Judicialização do Acesso a Medicamentos no Estado de Minas Gerais, Brasil,” Revista de Saúde Pública 45 (2011): 590–598, doi.org/10.1590/S0034-89102011005000015.CrossRefGoogle Scholar
Ventura, M., Simas, L., Pepe, V. L. E., and Schramm, F. R., “Judicialização da Saúde, Acesso à Justiça e a Efetividade do Direito à Saúde,” Physis: Revista de Saúde Coletiva 20 (2010): 77–100, doi.org/10.1590/S0103-73312010000100006; R. N. Sant’Ana, “A Judicialização Como Instrumento de Acesso à saúde: Propostas de Enfrentamento da Injustiça na Saúde Pública (2017).CrossRefGoogle Scholar
Senier, L., Lee, R., and Nicoll, L., “The Strategic Defense of Physician Autonomy: State Public Health Agencies as Countervailing Powers,” Social Science & Medicine 186 (2017): 113–121, doi.org/10.1016/j.socscimed.2017.06.007.CrossRefGoogle ScholarPubMed
See Machado, supra note 4; See Ventura, supra note 5; See Sant’Ana, supra note 5; See Senier, supra note 6; E. I. G. Andrade, C. D. Machado, D. R. Faleiros, D. A. C. Szuster, A. A. G. Júnior, G. D. da Silva, M. L. Cherchiglia, and F. de A. Acúrcio, “A Judicialização da Saúde e a Política Nacional de Assistência Farmacêutica no Brasil: Gestão da Clínica e Medicalização da Justiça,” 18 (n.d.) 46–50.Google Scholar
Conselho Nacional de Justiça – CNJ, Relatório Anual do Conselho Nacional de Justiça 2016. (2016).Google Scholar
See Machado, supra note 4.Google Scholar
See supra note 8.Google Scholar
Superior Tribunal de Justiça – STJ, Repetitivos e IACs. (n.d.).Google Scholar
Fischer, M. A. and Avorn, J., “Academic Detailing Can Play a Key Role in Assessing and Implementing Comparative Effectiveness Research Findings,” Health Affairs 31 (2012): 2206–2212, doi.org/10.1377/hlthaff.2012.0817; J. Avorn, “Academic Detailing: “Marketing” the Best Evidence to Clinicians,” JAMA 317 (2017): 361, doi.org/10.1001/jama.2016.16036.CrossRefGoogle ScholarPubMed
M. C. Borin, Avaliação de Viabilidade de Técnicas de Visitação Médica Para Detalhamento Acadêmico na Artrite Reumatoide, (2018); CCATES – Centro Colaborador do SUS Avaliação de Tecnologias e Excelência em Saúde, Diretriz – Detalhamento Acadêmico. (2015).Google Scholar
See CCATES, supra note 13.Google Scholar
Soumerai, S. B. and Avorn, J., “Economic and Policy Analysis of University-based Drug “Detailing” Medical Care 24 (1986): 313–331, doi.org/10.1097/00005650-198604000-00003.CrossRefGoogle ScholarPubMed
O’Brien, M. A., Rogers, S., Jamtvedt, G., Oxman, A., Odgaard-Jensen, J., Kristoffersen, D. T., Forsetlund, L., Bainbridge, D., Freemantle, N., Davis, D., Haynes, R. B., and Harvey, E., “Educational Outreach Visits: Effects on Professional Practice and Health Care Outcomes,” Cochrane Database of Systematic Reviews (2007), doi.org/10.1002/14651858.CD000409.pub2.CrossRefGoogle ScholarPubMed
See CCATES, supra note 13.Google Scholar
Goodman, L. A., “Snowball Sampling,” The Annals of Mathematical Statistics 32 (1961): 148–170.CrossRefGoogle Scholar
See Costa, supra note 2.Google Scholar
See Fischer, supra note 12; See Avorn, supra note 12; Brax, H., Fadlallah, R., Al-Khaled, L., Kahale, L. A., Nas, H., El-Jardali, F., and Akl, E. A., “Association Between Physicians’ Interaction with Pharmaceutical Companies and Their Clinical Practices: A Systematic Review and Meta-Analysis,” PLOS ONE 12 (2017): e0175493, doi.org/10.1371/journal.pone.0175493.CrossRefGoogle ScholarPubMed
Conselho Nacional de Justiça – CNJ, Perfil Sociodemográfico dos Magistrados Brasileiros 2018 (2018).Google Scholar
Smart, M. H., Mandava, M. R., Lee, T. A., and Pickard, A. S., “Feasibility and Acceptability of Virtual Academic Detailing on Opioid Prescribing,” International Journal of Medical Informatics 147 (2021): 104365, doi.org/10.1016/j.ijmedinf.2020.104365.CrossRefGoogle ScholarPubMed
See Machado, supra note 4; Superior Tribunal Federal – STF, Acórdão Recurso Extraordinário 657.718/MG. Relator: MELLO, Marco Aurélio Mendes de Farias. Publicado no DJ de 30/06/2017 (2017); Catanheide, I. D., Lisboa, E. S., and de Souza, L. E. P. F., “Características da Judicialização do Acesso a Medicamentos no Brasil: Uma Revisão Sistemática,” Physis: Revista de Saúde Coletiva 26 (2016): 1335–1356, doi.org/10.1590/s0103-73312016000400014.CrossRefGoogle Scholar
Uso Off Label: Erro ou Necessidade? Revista de Saúde Pública 46 (2012): 395–397, doi.org/10.1590/S0034-89102012000200026.CrossRefGoogle Scholar
See Senier, supra note 6.Google Scholar
Conselho Nacional de Justiça – CNJ, Resolução No 238 de 06/09/2016 (2016).Google Scholar
Trostle, J. A., “Medical Compliance as An Ideology,” Social Science & Medicine 27 (1988): 1299–1308, doi.org/10.1016/0277-9536(88)90194-3.CrossRefGoogle ScholarPubMed
See Senier, supra note 6.Google Scholar
See Senier, supra note 6.Google Scholar
Conselho Nacional de Justiça – CNJ, “Judicialização da Saúde no Brasil: Perfil das Demandas, Causas e Propostas de Solução,” (2019); Zimmermann, I. R., de Oliveira, E. F., Vidal, Á. T., Santos, V. C. C., and Petramale, C. A., “A Qualidade das Evidências e as Recomendações Sobre a Incorporação de Medicamentos no Sistema Único de Saúde: Uma Análise Retrospectiva,” Revista Eletronica Gestão & Saúde 6 (2015): 3043, doi.org/10.18673/gs.v6i4.22099.CrossRefGoogle Scholar
Groth, H. and Hodin, M., “How the EU Fails Patients Trying to Access Critical Medicines View,” Euronews (2019), available at <https://www.euronews.com/2019/04/09/how-the-eu-fails-patients-trying-to-access-critical-medicines-view> (last visited November 29, 2022).+(last+visited+November+29,+2022).>Google Scholar
WHO – Europe, Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research (2015).Google Scholar
Dunn, A., Whitmire, B., Batch, A., Fernando, L., and Rittmueller, L., “High Spending Growth Rates for Key Diseases In 2000–14 Were Driven by Technology and Demographic Factors,” Health Affairs 37 (2018): 915–924, doi.org/10.1377/hlthaff.2017.1688.CrossRefGoogle ScholarPubMed
Borin, M. C., Kakehasi, A. M., Dartnell, J., Junior, N. Gomes Ribeiro, F. de A. Acurcio, Junior, A. A. Guerra, and Alvares-Teodoro, J., “Academic Detailing Program for Rheumatoid Arthritis: A Contribution to Brazilian Public Health System Sustainability,” Journal of Pharmaceutical Health Services Research 11 (2020): 249–254, doi.org/10.1111/jphs.12365.CrossRefGoogle Scholar
See Conselho Nacional de Justiça – CNJ, supra note 30.Google Scholar